bristol myers squibb

Welcome to the 'bristol-myers squibb' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'bristol-myers squibb'.

Latest blogosphere posts tagged “bristol myers squibb”

• Alder Rides Momentum of $1B Deal, Aims to Give Amgen and Abbott a Run for Their Money

  
  Xconomy — Authority: 712
  Biotech , deals , people Luke Timmerman wrote: Alder Biopharmaceuticals keeps such a low profile that even after five years in business, few people in Seattle biotech know who they are. That changed yesterday as the private Bothell, WA-based company burst onto the local, and national, biotech scene by ...
  10 hours ago

• Clearwire Closes $1.5B, Alder Scores $1B Partnership, Software Financings Are Down, & More Seattle-Area Deals News

  
  Xconomy — Authority: 712
  Roundup , deals , VC Gregory T. Huang wrote: Healthcare deals are going one way, tech deals another. That’s my read from the past week in the Northwest, where we’ve seen some of the biggest biotech deals around, even as a prominent Seattle tech venture firm (and software financings in general) head ...
  21 hours ago

• Bristol-Myers Squibb to Present at Credit Suisse Healthcare Conference

  
  Pharmainfo.net — Authority: 164
  Bristol-Myers Squibb to Present at Credit Suisse Healthcare Conference Business Wire - 59 minutes ago NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) will present at a Credit Suisse healthcare conference on Thursday, November 12, 2009 in Phoenix, Arizona. Jean-Marc Huet ... Advertisement: ...
  1 day ago

• Alder Scores Deal With Bristol-Myers Potentially Worth $1 Billion

  
  Xconomy — Authority: 712
  Biotech , deals , Rheumatoid Arthritis Luke Timmerman wrote: Alder Biopharmaceuticals has just struck one of the biggest biotech partnerships of the year, both in the Seattle area and nationally. The Bothell, WA-based developer of faster and cheaper technology for making antibody drugs has formed a ...
  1 day ago

• Pharmalot… Pharmalittle… Morning Edition

  
  Pharmalot — Authority: 589
  Top of the morning, everyone. And a pleasant one, it is. Of course, rousting one of the short people from bed is proving challenging today - those of you with adolescents may understand. Still, we soldier on. And that calls for a cup of stimulation or two. While we brace ourselves, here are a few items to help you ...
  1 day ago

• FDA OKs Labeling Update for Reyataz Capsules

  
  Pharmainfo.net — Authority: 164
  FDA OKs Labeling Update for Reyataz Capsules Trading Markets - 45 minutes ago Nov 10, 2009 (Close-Up Media via COMTEX) -- BMY -- Bristol-Myers Squibb Company said that that the US Food and Drug Administration ( FDA ) has approved a labeling update for Reyataz to include long ... Advertisement: read more
  1 day ago

• (RX) Big Pharma and Biotech – Industry Outlook

  
  Stock Blog Hub — Authority: 506
  The pharmaceutical industry has witnessed major changes in 2009. Performance has been affected by factors like sluggish prescription trends, intensifying generic competition and limited phase III catalysts. The next five years are expected to reflect a significant imbalance between new product introductions and patent ...
  1 day ago

• Jim Cramer Names His Best Picks for Cancer Cures (BMY, IMGN, PFE, DNDN, EXEL)

  
  Pharmainfo.net — Authority: 164
  Jim Cramer Names His Best Picks for Cancer Cures (BMY, IMGN, PFE, DNDN, EXEL) Advertisement: read more
  1 day ago

• PM360 Trailblazer Awards Honor Company of the Year and 13 Top Brands and 13 Best Initiatives

  
  Pharmainfo.net — Authority: 164
  PM360 Trailblazer Awards Honor Company of the Year and 13 Top Brands and 13 Best Initiatives Newswire Today - 12 minutes ago NewswireToday - /newswire/ - Forest Hills, NY, United States, 11/09/2009 - Bristol-Myers Squibb named PM360 Trailblazer Innovation Awards Company of the Year; 13 Pharma and Medical Device ...
  1 day ago

• Universities Pledge Access To Poor Countries

  
  Pharmalot — Authority: 589
  There are five of them - Harvard University, Yale University, Brown University, the University of Pennsylvania and Boston University - will release a pledge to encourage companies to give poor countries better access to drugs and medical products based on discoveries made on their campuses, Bloomberg News reports. ...
  2 days ago

• Concert Starts HIV Trial, Bags $12M From Glaxo to Help Challenge Gilead’s Once-Daily Pill

  
  Xconomy — Authority: 712
  Biotech , deals , HIV Luke Timmerman wrote: Concert Pharmaceuticals, the Lexington, MA-based company that chemically modifies existing drugs to make them more attractive, has started human testing of an HIV medication which it hopes will help GlaxoSmithKline wrestle back market share it has been losing ...
  2 days ago

• Irving Kahn Buys Citigroup Inc., Pfizer Inc., Bristol-Myers Squibb Co., Astec Industries Inc., PattersonUTI Energy Inc.

  
  Pharmainfo.net — Authority: 164
  Irving Kahn Buys Citigroup Inc., Pfizer Inc., Bristol-Myers Squibb Co., Astec Industries Inc., PattersonUTI Energy Inc. Advertisement: read more
  2 days ago

• Abilify

  
  AdPharm Blog — Authority: 142
  Click here to see the original post on AdPharm Visit AdPharm.net for more pharmaceutical ads
  3 days ago

• Alca-Luftal – knot – woman

  
  AdPharm Blog — Authority: 142
  Click here to see it on AdPharm AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here .
  4 days ago

• Alca-Luftal – knot – man

  
  AdPharm Blog — Authority: 142
  Click here to see it on AdPharm AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here .
  4 days ago

• FDA Approves Labeling Update For REYATAZ(R) Capsules To Include 96-Week Data For Previously Untreated HIV-1 Infected Adult Patients

  
  Information on HPV — Authority: 144
  Bristol-Myers Squibb Company (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has approved a labeling update for REYATAZ® to include long-term data from the CASTLE Study. The CASTLE Study assessed a once-daily REYATAZ/ritonavir (REYATAZ/r)-based regimen versus a twice-daily lopinavir/ritonavir ...
  4 days ago

• IMS deal shows life, if not strength, in leveraged buyouts

  
  DealZone — Authority: 433
  (Recasts lead) If a deal can’t get done with the backing of Canada’s pension fund and capitalism’s mightiest bank, then the leveraged buyout market would truly be dead. So it is with limited fanfare that DealZone welcomes the buyout of IMS Health by Canada’s public pension plan and Goldman Sachs as a sign ...
  5 days ago

• BenchmarkJournal.com Free Analyst Review for BMY, ACF, FRE, TD, SWY and CBB

  
  Pharmainfo.net — Authority: 164
  BenchmarkJournal.com Free Analyst Review for BMY, ACF, FRE, TD, SWY and CBB SYS-CON Media - 23 minutes ago LONDON -- (Marketwire) -- 11/06/09 -- Benchmark Journal brings independent company and sector research together, utilizing top financial advisors and investment tactics to provide you with a clear ... ...
  5 days ago

• ZymoGenetics Reports Third Quarter 2009 Financial Results

  
  Pharmainfo.net — Authority: 164
  ZymoGenetics Reports Third Quarter 2009 Financial Results Reuters - 23 minutes ago http://www.businesswire.com/news/home/20091105005265/en Increased revenues and reduced expenses drive substantial improvement in quarterly net loss RECOTHROM sales increase to $8.5 million ... Advertisement: read more
  5 days ago

• InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone

  
  Pharmainfo.net — Authority: 164
  InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone Advertisement: read more
  6 days ago

Comments about bristol myers squibb